Literature DB >> 29167291

Candida auris: an Emerging Fungal Pathogen.

Emily S Spivak1, Kimberly E Hanson2,3.   

Abstract

Candida auris has emerged globally as a multidrug-resistant health care-associated fungal pathogen. Recent reports highlight ongoing challenges due to organism misidentification, high rates of antifungal drug resistance, and significant patient mortality. The predilection for transmission within and between health care facilities possibly promoted by virulence factors that facilitate skin colonization and environmental persistence is unique among Candida species. This minireview details the global emergence of C. auris and discusses issues relevant to clinical microbiology laboratories, hospital infection control, and antimicrobial stewardship efforts.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Candida auris; antifungal susceptibility; epidemiology; infection control

Mesh:

Substances:

Year:  2018        PMID: 29167291      PMCID: PMC5786713          DOI: 10.1128/JCM.01588-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry.

Authors:  Victoria Girard; Sandrine Mailler; Marion Chetry; Céline Vidal; Géraldine Durand; Alex van Belkum; Arnaldo L Colombo; Ferry Hagen; Jacques F Meis; Anuradha Chowdhary
Journal:  Mycoses       Date:  2016-06-13       Impact factor: 4.377

2.  Phylogeny and evolution of medical species of Candida and related taxa: a multigenic analysis.

Authors:  Stephanie Diezmann; Cymon J Cox; Gabriele Schönian; Rytas J Vilgalys; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

3.  Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis.

Authors:  Dharmendra Kumar; Tuhina Banerjee; Chandra Bhan Pratap; Ragini Tilak
Journal:  J Infect Dev Ctries       Date:  2015-04-15       Impact factor: 0.968

4.  Effectiveness of Disinfectants Against Candida auris and Other Candida Species.

Authors:  Jennifer L Cadnum; Aaron A Shaikh; Christina T Piedrahita; Thriveen Sankar; Annette L Jencson; Emily L Larkin; Mahmoud A Ghannoum; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2017-08-10       Impact factor: 3.254

5.  Incidence, characteristics and outcome of ICU-acquired candidemia in India.

Authors:  Arunaloke Chakrabarti; Prashant Sood; Shivaprakash M Rudramurthy; Sharon Chen; Harsimran Kaur; Malini Capoor; Deepinder Chhina; Ratna Rao; Vandana Kalwaje Eshwara; Immaculata Xess; Anupama J Kindo; P Umabala; Jayanthi Savio; Atul Patel; Ujjwayini Ray; Sangeetha Mohan; Ranganathan Iyer; Jagdish Chander; Anita Arora; Raman Sardana; Indranil Roy; B Appalaraju; Ajanta Sharma; Anjali Shetty; Neelam Khanna; Rungmei Marak; Sanjay Biswas; Shukla Das; B N Harish; Sangeeta Joshi; Deepak Mendiratta
Journal:  Intensive Care Med       Date:  2014-12-16       Impact factor: 17.440

6.  Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism.

Authors:  A Prakash; C Sharma; A Singh; P Kumar Singh; A Kumar; F Hagen; N P Govender; A L Colombo; J F Meis; A Chowdhary
Journal:  Clin Microbiol Infect       Date:  2015-11-05       Impact factor: 8.067

7.  Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts.

Authors:  E Cendejas-Bueno; A Kolecka; A Alastruey-Izquierdo; B Theelen; M Groenewald; M Kostrzewa; M Cuenca-Estrella; A Gómez-López; T Boekhout
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

8.  Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

Authors:  Kazuo Satoh; Koichi Makimura; Yayoi Hasumi; Yayoi Nishiyama; Katsuhisa Uchida; Hideyo Yamaguchi
Journal:  Microbiol Immunol       Date:  2009-01       Impact factor: 1.955

9.  First hospital outbreak of the globally emerging Candida auris in a European hospital.

Authors:  Silke Schelenz; Ferry Hagen; Johanna L Rhodes; Alireza Abdolrasouli; Anuradha Chowdhary; Anne Hall; Lisa Ryan; Joanne Shackleton; Richard Trimlett; Jacques F Meis; Darius Armstrong-James; Matthew C Fisher
Journal:  Antimicrob Resist Infect Control       Date:  2016-10-19       Impact factor: 4.887

10.  The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.

Authors:  Emily Larkin; Christopher Hager; Jyotsna Chandra; Pranab K Mukherjee; Mauricio Retuerto; Iman Salem; Lisa Long; Nancy Isham; Laura Kovanda; Katyna Borroto-Esoda; Steve Wring; David Angulo; Mahmoud Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

View more
  79 in total

1.  Preparing your healthcare facility for the new fungus among us: An infection preventionist's guide to Candida auris.

Authors:  Tina Z Wang; Kindra N White; Jillian Villani Scarr; Matthew S Simon; David P Calfee
Journal:  Am J Infect Control       Date:  2020-07       Impact factor: 2.918

2.  Cloning and heterologous expression of P450Lent4B11, a novel bacterial P450 gene, for hydroxylation of an antifungal agent sordaricin.

Authors:  Motoi Ueno; Motoo Kobayashi; Akihiko Fujie; Takashi Shibata
Journal:  J Antibiot (Tokyo)       Date:  2020-05-01       Impact factor: 2.649

3.  SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents.

Authors:  Krupanandan Haranahalli; Cristina Lazzarini; Yi Sun; Julia Zambito; Senuri Pathiranage; J Brian McCarthy; John Mallamo; Maurizio Del Poeta; Iwao Ojima
Journal:  J Med Chem       Date:  2019-08-16       Impact factor: 7.446

Review 4.  Molecular Diagnostic Advances in Transplant Infectious Diseases.

Authors:  Brittany A Young; Kimberly E Hanson; Carlos A Gomez
Journal:  Curr Infect Dis Rep       Date:  2019-11-26       Impact factor: 3.725

Review 5.  Candida auris: a fungus with identity crisis.

Authors:  Taissa Vila; Ahmed S Sultan; Daniel Montelongo-Jauregui; Mary Ann Jabra-Rizk
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

6.  Experimental Evolution Identifies Adaptive Aneuploidy as a Mechanism of Fluconazole Resistance in Candida auris.

Authors:  Jian Bing; Tianren Hu; Qiushi Zheng; José F Muñoz; Christina A Cuomo; Guanghua Huang
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

7.  Misidentification of Candida auris by RapID Yeast Plus, a Commercial, Biochemical Enzyme-Based Manual Rapid Identification System.

Authors:  Mary Snayd; Feliciano Dias; Raymond W Ryan; Donna Clout; David B Banach
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

8.  Locus CauMT1 Provides a Higher-Resolution Alternative to Ribosomal Gene Sequencing for Initial Candida auris Genotyping.

Authors:  Santosh Katiyar; Tom Edlind
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

9.  Human Infections Caused by Clonally Related African Clade (Clade III) Strains of Candida auris in the Greater Houston Region.

Authors:  S Wesley Long; Matthew Ojeda Saavedra; Paul A Christensen; James M Musser; Randall J Olsen
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

10.  A Selective Medium for Isolation and Detection of Candida auris, an Emerging Pathogen.

Authors:  Sourav Das; Shreya Singh; Yamini Tawde; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Harsimran Kaur; Shamanth A Shankarnarayan; Anup Ghosh
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.